Get the Stockscreener App
80.13
0.61%
-0.49
After Hours:
80.13
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $80.13, with a volume of 1.38M.
It is down -0.61% in the last 24 hours and up +1.86% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$80.62
Open:
$80.35
24h Volume:
1.38M
Relative Volume:
0.74
Market Cap:
$39.36B
Revenue:
$10.19B
Net Income/Loss:
$1.05B
P/E Ratio:
38.08
EPS:
2.1044
Net Cash Flow:
$1.38B
1W Performance:
+3.26%
1M Performance:
+1.86%
6M Performance:
-7.88%
1Y Performance:
-4.28%
1-Day Range:
$78.86
$80.64
1-Week Range:
$78.49
$82.50
52-Week Range:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
80.13 | 39.60B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
586.24 | 207.41B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
202.75 | 58.46B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
252.47 | 36.63B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.52 | 32.47B | 27.43B | 1.27B | 1.01B | 1.5829 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Stifel Downgrades Alcon (ALC) and Lowers Target Price to $80.00 - GuruFocus
STAAR Surgical Stock (STAA) Opinions on Failed Alcon Merger - Quiver Quantitative
STAAR Surgical and Alcon terminate proposed merger - Eyes On Eyecare
Intraocular Lens Market Size to Reach USD 9.85 Billion by 2033, Growing at a CAGR of 6.48% - GlobeNewswire Inc.
Stifel downgrades Alcon stock to Hold on UNITY survey concerns By Investing.com - Investing.com India
Stifel downgrades Alcon stock to Hold on UNITY survey concerns - Investing.com
How sustainable is Alcon Inc. stock dividend payoutJuly 2025 Setups & AI Optimized Trade Strategies - ulpravda.ru
Alcon Inc.'s (VTX:ALC) Intrinsic Value Is Potentially 56% Above Its Share Price - Yahoo Finance
Is Alcon Inc. stock trading at a premium valuationEarnings Summary Report & Scalable Portfolio Growth Methods - ulpravda.ru
Is Alcon Inc. stock a buy on dipsMarket Growth Summary & High Accuracy Swing Entry Alerts - ulpravda.ru
Is Alcon Inc. Ordinary Shares stock supported by strong fundamentalsTrade Exit Summary & Accurate Trade Setup Notifications - ulpravda.ru
Revenue Check: Why Alcon Inc. Ordinary Shares stock could outperform next yearDollar Strength & AI Powered Buy/Sell Recommendations - ulpravda.ru
What Wall Street predicts for Alcon Inc. stock priceTrade Volume Summary & High Conviction Investment Ideas - ulpravda.ru
STAAR Surgical holder Yunqi Capital purchased 750K shares for $21.53 - MSN
Does Alcon Inc. stock trade at a discount to peers2025 Market Outlook & Daily Profit Focused Stock Screening - ulpravda.ru
Alcon Inc. stock: steady vision, selective enthusiasm as investors weigh medical-tech defensiveness - AD HOC NEWS
Can Alcon Inc. stock sustain revenue growth2025 Support & Resistance & Precise Swing Trade Alerts - ulpravda.ru
STAAR Surgical sinks as it plans to terminate sale to Alcon - MSN
Why Alcon Inc. Ordinary Shares stock could outperform next yearJuly 2025 Review & Fast Moving Stock Trade Plans - ulpravda.ru
Is Alcon Inc. stock recession proofSwing Trading Watchlist & Market Monitoring and Alerts - ulpravda.ru
Alcon terminates agreement to purchase STAAR Surgical - MSN
STAAR Surgical terminates Alcon merger agreement - Yahoo Finance
Alcon Walks Away From STAAR Surgical Deal, Reaffirms Refractive Strategy - TipRanks
Alcon terminates agreement to acquire STAAR Surgical - MarketScreener
Recent uptick might appease Alcon Inc. (VTX:ALC) institutional owners after losing 15% over the past year - simplywall.st
Alcon Terminates Agreement to Acquire STAAR Surgical - Yahoo Finance
Alcon (ALC) Ends Merger with Staar Surgical; Focuses on Refracti - GuruFocus
Alcon Terminates Merger Agreement with STAAR, Focuses on New Product Launches - Intellectia AI
Alcon terminates merger agreement with STAAR Surgical By Investing.com - Investing.com Australia
Alcon terminates merger agreement with STAAR Surgical - Investing.com
STAAR Surgical Company Shareholders Reject Merger Proposal with Alcon Research, LLC - MarketScreener
STAAR Surgical sinks as it plans to terminate sale to Alcon (update) (STAA:NASDAQ) - Seeking Alpha
Staar, Alcon Deal to Fizzle - Medical Device and Diagnostic industry
STAAR Stock Drops 10% After Shareholders Reject Alcon Merger Proposal - Nasdaq
STAAR Surgical's proposed merger with Alcon falls through as shareholders reject the deal - Bitget
STAAR Surgical Merger With Alcon Fails After Shareholders Vote No - Benzinga
Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing - MarketScreener
STAAR shareholders reject Alcon’s revised buyout offer - MedTech Dive
Alcon (ALC) Acquisition Proposal Rejected by STAAR Shareholders - GuruFocus
Alcon (ALC) Faces Uncertain Future After Failed Staar Surgical D - GuruFocus
Alcon (ALC) Merger With Staar Surgical Fails to Secure Stockholder Approval - GuruFocus
STAAR shareholders reject Alcon acquisition bid By Investing.com - Investing.com India
Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win - MarketScreener
STAAR Surgical (STAA) Shares Drop 19% After Alcon Deal Terminati - GuruFocus
Staar Surgical did not receive votes to approve Alcon merger at special meeting of stockholders - MarketScreener
STAAR Surgical Shareholders Reject Proposed Alcon Merger; Shares Fall - MarketScreener
Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon - marketscreener.com
STAAR shareholders just rejected a proposed sale of the company to Alcon - Stock Titan
STAAR Surgical Says It Plans to Terminate Merger Deal with Alcon - Medical Product Outsourcing
STAAR Surgical to Terminate Alcon Merger, Stay Independent - TipRanks
STAAR Surgical to remain independent after failed Alcon merger vote By Investing.com - Investing.com Canada
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
1.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):